USD 18.5
(-0.54%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | -77.13 Million | -9.15 Million | 12.52 Million | 68.65 Million | -13.63 Million | 53.37 Million |
Net Income | -127.84 Million | -5.81 Million | -64.74 Million | -49.16 Million | -8.9 Million | 12.78 Million |
Depreciation & Amortization | 37.01 Million | 24.61 Million | 26.24 Million | 25.75 Million | 42.3 Million | 26.48 Million |
Deferred income taxes | -129 Thousand | 581 Thousand | -834 Thousand | 4.35 Million | -2.99 Million | - |
Stock-based compensation | 2.66 Million | 2.7 Million | 2.53 Million | 2.51 Million | 4.12 Million | - |
Change in working capital | -36.36 Million | -4.36 Million | -4.06 Million | 71.73 Million | -62.24 Million | 22.28 Million |
Other non-cash items | 112.45 Million | 12.12 Million | 124.62 Million | 46.25 Million | 186.65 Million | 49.59 Million |
Investing Cash Flow | 49.35 Million | 55.41 Million | 42.07 Million | -15.75 Million | -40.36 Million | -7.27 Million |
Investments in PPE | -5.15 Million | -8.49 Million | -4.3 Million | -18.07 Million | -22.06 Million | -12.69 Million |
Acquisitions | 16.26 Million | 29.01 Million | 46.37 Million | 2.31 Million | -18.3 Million | 2.06 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | 3.35 Million |
Other Investing Activities | 38.24 Million | 34.9 Million | 46.37 Million | 2.31 Million | 1.65 Million | - |
Financing Cash Flow | 30.26 Million | -16.3 Million | -31.51 Million | -53.66 Million | 28.63 Million | -14.84 Million |
Debt repayment | -2.16 Million | -28.62 Million | -54.03 Million | -50.61 Million | -27.63 Million | -113.57 Million |
Dividends payments | - | - | - | - | -686 Thousand | -136.08 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 28.8 Million | 13 Million | 24.25 Million | - | 59.24 Million | 10 Million |
Other Financing Activities | -700 Thousand | -677 Thousand | -1.73 Million | -3.04 Million | -2.27 Million | -2.33 Million |
Accounts receivables | 3.6 Million | 105 Thousand | -21.79 Million | 10.2 Million | -87.2 Million | -4.74 Million |
Accounts payables | 7.07 Million | 13.63 Million | -457 Thousand | -69 Thousand | 9.08 Million | 1.08 Million |
Inventory | 1.08 Million | -803 Thousand | 6.03 Million | 11.08 Million | -5.72 Million | -1.15 Million |
Other working capital | -48.12 Million | -17.3 Million | 12.14 Million | 50.5 Million | 21.59 Million | 27.08 Million |
Cash at beginning of period | 59.17 Million | 29.21 Million | 5.91 Million | 6.9 Million | 32.26 Million | 1 Million |
Cash at end of period | 61.65 Million | 59.17 Million | 29.21 Million | 5.91 Million | 6.9 Million | 32.26 Million |
Capital Expenditure | -5.15 Million | -8.49 Million | -4.3 Million | -18.07 Million | -22.06 Million | -12.69 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 2.48 Million | 29.96 Million | 23.29 Million | -988 Thousand | -25.36 Million | 31.26 Million |
Free Cash Flow | -82.28 Million | -17.65 Million | 8.21 Million | 50.58 Million | -35.7 Million | 40.68 Million |
Breakdown | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6.08 Million | -127.84 Million | -92.84 Million | -13.35 Million | -9.6 Million | -12.04 Million |
Depreciation & Amortization | 6.78 Million | 37.01 Million | 16.62 Million | 7 Million | 6.81 Million | 6.57 Million |
Deferred income taxes | 75 Thousand | -129 Thousand | -439 Thousand | -51 Thousand | 325 Thousand | 36 Thousand |
Stock-based compensation | 752 Thousand | 2.66 Million | 289 Thousand | 834 Thousand | - | 791 Thousand |
Change in working capital | -19.07 Million | -36.36 Million | 5.36 Million | -20.05 Million | -7.84 Million | -13.83 Million |
Other non-cash items | 16.78 Million | 112.45 Million | 79.35 Million | 31.72 Million | -3.69 Million | 5.06 Million |
Investing Cash Flow | 3.17 Million | 49.35 Million | 2.81 Million | 3.05 Million | 42.51 Million | 969 Thousand |
Investments in PPE | -63 Thousand | -5.15 Million | -1.49 Million | -507 Thousand | -1.02 Million | -2.12 Million |
Acquisitions | 3.23 Million | 16.26 Million | 4.31 Million | 3.55 Million | 5.29 Million | 3.09 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 3.23 Million | 38.24 Million | 1000.00 | 3.55 Million | 38.23 Million | 3.09 Million |
Financing Cash Flow | 3.37 Million | 30.26 Million | 18.13 Million | 20.26 Million | -5.13 Million | -2.99 Million |
Debt repayment | -3.37 Million | -2.16 Million | -10.66 Million | -20.26 Million | -4.43 Million | -2.99 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 28.8 Million | 28.8 Million | - | - | - |
Other Financing Activities | 6.05 Million | -700 Thousand | 2.85 Million | 25.99 Million | -700 Thousand | -482 Thousand |
Accounts receivables | -1.23 Million | 3.6 Million | 5.74 Million | -7.77 Million | 5.36 Million | 279 Thousand |
Accounts payables | -3.69 Million | 7.07 Million | 6.34 Million | -10.6 Million | 9.67 Million | 1.65 Million |
Inventory | 218 Thousand | 1.08 Million | 1.69 Million | -1.73 Million | -376 Thousand | 1.49 Million |
Other working capital | -14.36 Million | -48.12 Million | 3.18 Million | 56 Thousand | -22.5 Million | -17.26 Million |
Cash at beginning of period | 61.65 Million | 59.17 Million | 52.1 Million | 57.64 Million | 33.23 Million | 59.17 Million |
Cash at end of period | 48.41 Million | 61.65 Million | 61.65 Million | 52.1 Million | 57.64 Million | 33.23 Million |
Capital Expenditure | -63 Thousand | -5.15 Million | -1.49 Million | -507 Thousand | -1.02 Million | -2.12 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -13.24 Million | 2.48 Million | 9.55 Million | -5.54 Million | 24.4 Million | -25.93 Million |
Free Cash Flow | -19.85 Million | -82.28 Million | -12.89 Million | -29.36 Million | -13.99 Million | -26.03 Million |
PRTG
NSRGF
RIWI
BALPHARMA
CYBERTECH
AVPMF